Alector (ALEC) EBITDA (2018 - 2026)
Alector (ALEC) reported EBITDA of -$23.2 million for Q1 2026, up 42.77% year-over-year from -$16.2 million in Q1 2025, and up 37.8% quarter-over-quarter from -$37.3 million in Q4 2025.
Alector (ALEC) EBITDA (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of EBITDA data on file, last reported at -$23.2 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$23.2 million, up 42.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$125.7 million (down 2.31% YoY), and the FY2025 annual result was -$143.0 million, down 20.22% from the prior year.
- EBITDA advanced to -$23.2 million in Q1 2026 per ALEC's latest filing, from -$37.3 million in the prior quarter.
- Over five years, EBITDA peaked at $7.6 million in Q2 2022 and troughed at -$50.3 million in Q4 2022.
- A 5-year average of -$32.2 million and a median of -$38.9 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2022 and 2024: EBITDA soared 113.72% in 2022, then slumped 1877.56% in 2024.
- A 5-year view of EBITDA shows it stood at -$50.3 million in 2022, then rose by 19.36% to -$40.5 million in 2023, then jumped by 93.23% to -$2.7 million in 2024, then slumped by 1259.26% to -$37.3 million in 2025, then soared by 37.8% to -$23.2 million in 2026.
- Business Quant data shows ALEC's EBITDA at -$23.2 million in Q1 2026, -$37.3 million in Q4 2025, and -$34.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -23.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.20 Mn |
| Dec 31, 2025 | -37.30 Mn |
| Sep 30, 2025 | -34.57 Mn |
| Jun 30, 2025 | -30.62 Mn |
| Mar 31, 2025 | -40.54 Mn |
| Dec 31, 2024 | -2.74 Mn |
| Sep 30, 2024 | -40.67 Mn |
| Jun 30, 2024 | -38.89 Mn |
| Mar 31, 2024 | -36.67 Mn |
| Dec 31, 2023 | -40.53 Mn |
| Sep 30, 2023 | -43.81 Mn |
| Jun 30, 2023 | 2.19 Mn |
| Mar 31, 2023 | -43.48 Mn |
| Dec 31, 2022 | -50.26 Mn |
| Sep 30, 2022 | -46.67 Mn |
| Jun 30, 2022 | 7.59 Mn |
| Mar 31, 2022 | -47.61 Mn |
| Dec 31, 2021 | -56.51 Mn |
| Sep 30, 2021 | 126.35 Mn |
| Jun 30, 2021 | -55.35 Mn |